logo-loader
viewPRO MEDICUS LIMITED

Pro Medicus moves to profitability

au_business_news_350_53f6b5904c99f.jpg

Pro Medicus (ASX: PME) is expected to trade higher after reporting a net profit after tax of $1.51 million for its continuing operations for the year ended 30 June 2014, compared with a loss of $3.48 million in the previous year.

The key driver was revenue from new contracts in the U.S. and the start of revenue from a contract with the U.S. health system that was signed in April. 

This contract is structured on an operational model, based on transaction numbers, so revenue will grow as PME's product is installed across more of the customer’s network. 

This means revenue should continue to build toward the second half of this year.

Full year revenue from continuing operations increased from $11.37 million to $14.45 million, an increase of 27.1%.

Underlying operations for the year delivered profit of $1.58 million, compared to an underlying loss of $0.65 million from the previous year.

The underlying profit is made up of reported profit after-tax of $1.51 million and adding back the after-tax net currency loss of $0.07 million. 

EBIT was $2.27 million, up from a loss of $0.52 million, with the second half bringing EBIT of $2.15 million compared with $0.12 million in the first half. 

PME provides radiology information systems, digital radiology integration products and innovative clinical software, and is valued at around $90 million.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: PRO MEDICUS LIMITED

Price: 26.49 AUD

ASX:PME
Market: ASX
Market Cap: $2.75 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Electric vehicle sales to accelerate following coronavirus pandemic

Roskill analyst Jose Lazuen tells Proactive London's Andrew Scott severe falls were expected in EV sales but that European and Chinese policies coupled with consumer preferences have shown them to remain strong. He adds that policy is going to favour and push EV sales in certain jurisdictions...

1 day, 13 hours ago

2 min read